head_banner

News

Moderna akataura kuti yapedza iyo FDA yekubvumidza kuzere chikumbiro chekudzivirira kweCOVID, iyo inotengeswa seSpikevax kunze kwenyika.
Kwete kuti ipere, Pfizer neBioNTech vakataura kuti vachaendesa data rasara pamberi pesvondo rino kuti vabvumire jekiseni ravo reCOVID booster.
Kutaura nezve boosters, iyo yechitatu dosi yemRNA COVID-19 yekudzivirira inogona kutanga mwedzi mitanhatu mushure mekupedzisira dosi panzvimbo yemwedzi misere yakamboziviswa.(Wall Street Journal)
Gavhuna achangobva kugadzwa weNew York State Kathy Hochul (D) akataura kuti nyika ichazivisa zviri pamutemo nyaya dzinosvika zviuru gumi nezviviri dzeCOVID-12,000 dzisina kuverengwa neakafanomutangira-zvisinei, nhamba idzi dzakatoverengerwa muCDC statistics, uye tracker iri sezvinotevera. Show.(Associated Press)
Kubva na8 am Eastern Time nemusi weChina, huwandu hwevakafa vasina pamutemo hweCCIDID-19 muUnited States hwakasvika makumi matatu nemasere,225,849 uye 632,283 vafa, kuwedzera kwe148,326 uye 1,445 zvakateerana kubva panguva ino nezuro.
Huwandu hwevanhu vafa hunosanganisira mukoti ane makore makumi matatu nematatu asina kuvharirwa muAlabama akafa mushure mekuiswa muchipatara neCCIDID-19 kutanga kwemwedzi uno;mwana wake akanga asati aberekwa akafawo.(NBC Nhau)
Kutevera kuwanda kwenyaya muTexas, National Rifle Association yakadzima musangano wayo wepagore muHouston mukutanga kwaGunyana.(NBC Nhau)
Iyo yakagadziridzwa NIH nhungamiro yeyakakomba COVID-19 ikozvino inoti intravenous sarilumab (Kevzara) uye tofacitinib (Xeljanz) inogona kushandiswa musanganiswa nedexamethasone, zvichiteerana, se tocilumab (Actemra) uye baritinib (Olumiant) Alternatives, kana imwe yadzo isiri. iripo.
Panguva imwecheteyo, sangano iri rakaitawo mhemberero yekucheka ribhoni kuhofisi yayo itsva yeSoutheast Asia muVietnam.
Ascendis Pharma yakazivisa kuti mune zvakatevedzana zveFDA nhau, iyo yakareba-inobata prodrug yekukura kwehomoni-lonapegsomatropin (Skytrofa) -yakabvumidzwa sekutanga kwevhiki kurapwa kwekushaikwa kwehomoni muvana vane makore 1 uye kupfuura.
Servier Pharmaceuticals yakataura kuti ivosidenib (Tibsovo) inogona kushandiswa sechipiri-mutsara kurapwa kune vanhu vakuru vane IDH1 mutations mune advanced cholangiocarcinoma.
Iyo FDA yakapa Kirasi I zita rekuyeuka mamwe akagadziridzwa BD Alaris infusion pombi nekuti yakatyoka kana kuvharika baffle post mumudziyo inogona kukonzera kukanganisa, kusaburitsa, kana kuwandisa-kuunza mvura kumurwere.
Vati tarisa N95 yako kuti uone kuti haina kugadzirwa neShanghai Dasheng, nekuti masks ekambani haachatenderwe kushandiswa nekuda kwehurombo hwehutongi.
Unoda kufadza vateveri vako pasocial media neiyo Milk Bhokisi Dambudziko?Usaite izvi, chiremba anovhiya epurasitiki weAtlanta akati akanyevera kuti zvinogona kutungamirira kukukuvara kwehupenyu hwose.(NBC Nhau)
Panyaya yehutano hwepfungwa, Mutungamiri Biden vakasaina bhiri rekubvumidza veterans vane post-traumatic stress disorder kudzidzisa uye kutora imbwa dzebasa.(Nyeredzi yemauto bheji uye armband)
CDC yazvino data inoratidza kuti inopfuura makumi matanhatu muzana yevanokodzera vagari vemuUS vakabaiwa zvizere kurwisa COVID.Heino nzira yehutano inogona kuteedzera avo vanotsvedza nemumikaha mumishandirapamwe yekudzivirira.(nhamba)
Iyo Pennsylvania-yakavakirwa Geisinger Health System yakataura kuti semamiriro ebasa, zvinoda kuti vashandi vayo vese vabaiwe nhomba yeCOVID-19 pakati paGumiguru.
Zvichakadaro, kambani yeDelta Air Lines ichabhadharisa vashandi vanenge vasina kubaiwa madhora mazana maviri pamwedzi.(Bloomberg nzira)
Kushambadzira kwepamhepo kunonangana nevanochengetedza tout kuti COVID yekudzivirira "inovimbwa nemauto eUS" uye "pfuti yekudzoreredza rusununguko rwedu."(Houston Chronicle)
Zvishandiso zviri pawebhusaiti ino ndezvekutarisa chete uye hazvisi zvinotsiva zano rekurapa, kuongororwa kana kurapwa kunopihwa nevanopa hutano hwehutano.© 2021 MedPage Nhasi, LLC.kodzero dzose dzakachengetedzwa.Medpage Nhasi ndeimwe yemubatanidzwa akanyoreswa zviratidzo zveMedPage Nhasi, LLC uye haigone kushandiswa nevechitatu mapato pasina mvumo.


Nguva yekutumira: Sep-22-2021